Purchase Order 75N95D24P00097
Award Date 8/21/24
Potential Completion Date 11/20/24
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Potomac, MD 20878, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health (NIH) awarded a $14,565 firm-fixed price purchase order contract to Biohippo Inc., a self-certified small disadvantaged business, to provide services to generate conditional knockout mouse models using CRISPR/Cas9 technology. This contract was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency, and has a completion date of April 30, 2023. Biohippo Inc. is an experienced provider of specialized laboratory equipment,...
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $14,000 purchase order to Biohippo Inc. to deliver research animal/direct use - custom service animal model construction. As the prime contractor, Biohippo Inc. will construct custom animal models to support biomedical research being conducted by the National Institute on Aging. The firm-fixed price contract runs from December 2023 through June 2024 for model development at...
- This federal contract award, valued at $5,500.00, was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency under the National Institutes of Health (NIH), to Biohippo Inc., a self-certified small disadvantaged business. The award is for the provision of PLVAP1-CRE-ER mice, a specialized animal model, to support research on vascular fenestrations in the central nervous system. The contract is a firm-fixed-price purchase order with a completion date of...
- This is a firm-fixed price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the National Institutes of Health (NIH), to Biohippo Inc., a self-certified small disadvantaged business. The $13,000.00 contract is for Biohippo Inc. to provide the C57BL/6SMOC-ESR2EM1(IRES-CREERT2)SMOC mouse line for use in NIDCD research protocol 1626. The award does not have a set-aside designation. Biohippo Inc. is the prime contractor...
- The federal contract award to Biohippo Inc. has an award value of $13,000.00 and was issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency under the National Institutes of Health. The contract is for the delivery of FOLR2-CRE-2A-TDTOMATO mice, which are specialized biomedical research animal models. The contract does not have a set-aside designation. Biohippo Inc. is a self-certified small disadvantaged business that has previously provided...
- This is a firm-fixed price purchase order award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the National Institutes of Health (NIH), to Biohippo Inc., a self-certified small disadvantaged business. The $15,000.00 contract is for animal model construction services to support NIAAA's biomedical research initiatives. Biohippo Inc. has a history of providing specialized laboratory equipment and gene-related services to various NIH institutes. This...
- The National Institute on Aging (NIA), on behalf of the National Institute on Drug Abuse (NIDA), awarded a $25,098.00 firm fixed-price purchase order to Ingenious Targeting Laboratory Inc., a minority-owned, small disadvantaged business, for a Custom Conditional Gpnmb cDNA cassette Knockin mouse model. The purpose is to generate a Cre-inducible Gpnmb-diphtheria toxin receptor (DTR) knock-in mouse to study the role of GPNMB+ macrophages in skeletal muscle injury response and aging. The period...
- This firm-fixed-price purchase order was awarded by the National Institute on Alcohol Abuse and Alcoholism, a civilian agency within the U.S. Department of Health and Human Services, to Biohippo Inc. for an animal strain license in the amount of $12,000.00. Biohippo Inc. is a self-certified small disadvantaged business that specializes in providing biomedical research services and equipment to various institutes within the National Institutes of Health. This award did not have a set-aside...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a part of the National Institutes of Health (NIH), to Gempharmatech LLC, a biotechnology company that specializes in developing humanized animal models. The contract is for the provision of a conditional knock-out mouse line to support NICHD's research. The contract has a ceiling value of $17,225 and a period of performance ending on August 31, 2022. Gempharmatech LLC has...
- This is a $18,243.50 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Cyagen Biomodels LLC, a for-profit biotechnology company in Santa Clara, California. The contract is for laboratory research to generate a mouse YWHAE (N terminal-EGFP) knockin project on a C57BL/6J genetic background. This specialized genetic engineering service supports advanced scientific investigations across multiple...
The National Institute on Aging, a civilian agency within the National Institutes of Health (NIH), awarded a firm-fixed price purchase order contract to Biohippo Inc., a self-certified small disadvantaged business, for the construction of a custom conditional knockout mouse. The contract has a ceiling value of $24,500.00 and a period of performance ending on November 20, 2024. Biohippo Inc. has a history of providing biomedical research services and equipment to various NIH institutes, including the construction of custom animal models and the generation of conditional knockout mouse models using CRISPR/Cas9 technology. This contract does not have a set-aside designation.
Generated 8/22/24, 3:35 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.5k | 8/21/24 |